...
search icon
alks-img

Alkermes Plc, Common Stock

ALKS

NSQ

$29.47

-$0.28

(-0.94%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$4.99B
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
12.869
Volume info-icon
This is the total number of shares traded during the most recent trading day.
0
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0.43
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$22.9 L
$32.88 H
$29.47

About Alkermes Plc, Common Stock

Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in therapeutic areas in the United States, Ireland, and internationally. It has a portfolio of proprietary commercial products for the treatment of alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder and a pipeline of clinical and preclinical product candidates in development for neurological disorders. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ARISTADA INITIO for the treatment of schizophrenia in adults; VIVITROL for the treatment of alcohol and prevention of opioid dependence; and LYBALVI, an oral atypical antipsychotic drug candidate for the treatment of adults with schizophrenia and bipolar I disorder. It has collaboration agreements primarily with Janssen Pharmaceutica N.V., Janssen Pharmaceutica Inc, and Janssen Pharmaceutica International. The company also offers proprietary technology platforms to third parties to enable them to develop, commercialize, and manufacture products. Alkermes plc was founded in 1987 and is headquartered in Dublin, Ireland. more

Industry: BiotechnologySector: Health Care

Returns

Time FrameALKSSectorS&P500
1-Week Return4.95%1.07%1.94%
1-Month Return-4.16%1.38%-2.02%
3-Month Return4.02%-7.39%1.67%
6-Month Return19.75%-6.25%6.34%
1-Year Return6.43%1.24%25.38%
3-Year Return16.85%6.76%29.66%
5-Year Return53.17%35.07%78.4%
10-Year Return-58.37%100.55%193.77%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue1.17B1.04B1.17B1.11B1.66B[{"date":"2019-12-31","value":70.39,"profit":true},{"date":"2020-12-31","value":62.45,"profit":true},{"date":"2021-12-31","value":70.56,"profit":true},{"date":"2022-12-31","value":66.84,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Cost of Revenue693.22M572.90M603.91M218.11M253.04M[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":82.64,"profit":true},{"date":"2021-12-31","value":87.12,"profit":true},{"date":"2022-12-31","value":31.46,"profit":true},{"date":"2023-12-31","value":36.5,"profit":true}]
Gross Profit477.73M465.85M569.84M893.69M1.41B[{"date":"2019-12-31","value":33.87,"profit":true},{"date":"2020-12-31","value":33.03,"profit":true},{"date":"2021-12-31","value":40.4,"profit":true},{"date":"2022-12-31","value":63.37,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Gross Margin40.80%44.85%48.55%80.38%84.79%[{"date":"2019-12-31","value":48.12,"profit":true},{"date":"2020-12-31","value":52.89,"profit":true},{"date":"2021-12-31","value":57.26,"profit":true},{"date":"2022-12-31","value":94.8,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Operating Expenses639.81M578.28M599.13M1.04B996.25M[{"date":"2019-12-31","value":61.76,"profit":true},{"date":"2020-12-31","value":55.82,"profit":true},{"date":"2021-12-31","value":57.83,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":96.17,"profit":true}]
Operating Income(162.08M)(112.43M)(26.66M)(142.26M)414.12M[{"date":"2019-12-31","value":-39.14,"profit":false},{"date":"2020-12-31","value":-27.15,"profit":false},{"date":"2021-12-31","value":-6.44,"profit":false},{"date":"2022-12-31","value":-34.35,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]
Total Non-Operating Income/Expense(34.60M)14.19M(145.86M)(30.45M)15.22M[{"date":"2019-12-31","value":-227.37,"profit":false},{"date":"2020-12-31","value":93.25,"profit":true},{"date":"2021-12-31","value":-958.43,"profit":false},{"date":"2022-12-31","value":-200.08,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]
Pre-Tax Income(197.06M)(96.54M)(39.31M)(167.30M)421.52M[{"date":"2019-12-31","value":-46.75,"profit":false},{"date":"2020-12-31","value":-22.9,"profit":false},{"date":"2021-12-31","value":-9.32,"profit":false},{"date":"2022-12-31","value":-39.69,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]
Income Taxes(436.00K)14.32M8.86M(9.04M)(97.64M)[{"date":"2019-12-31","value":-3.04,"profit":false},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":61.88,"profit":true},{"date":"2022-12-31","value":-63.09,"profit":false},{"date":"2023-12-31","value":-681.64,"profit":false}]
Income After Taxes(196.62M)(110.86M)(48.17M)(158.27M)519.16M[{"date":"2019-12-31","value":-37.87,"profit":false},{"date":"2020-12-31","value":-21.35,"profit":false},{"date":"2021-12-31","value":-9.28,"profit":false},{"date":"2022-12-31","value":-30.49,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]
Income From Continuous Operations(196.62M)(110.86M)(48.17M)(158.27M)519.16M[{"date":"2019-12-31","value":-37.87,"profit":false},{"date":"2020-12-31","value":-21.35,"profit":false},{"date":"2021-12-31","value":-9.28,"profit":false},{"date":"2022-12-31","value":-30.49,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(196.62M)(110.86M)(48.17M)(158.27M)355.76M[{"date":"2019-12-31","value":-55.27,"profit":false},{"date":"2020-12-31","value":-31.16,"profit":false},{"date":"2021-12-31","value":-13.54,"profit":false},{"date":"2022-12-31","value":-44.49,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]
EPS (Diluted)0.710.430.780.341.42[{"date":"2019-12-31","value":50,"profit":true},{"date":"2020-12-31","value":30.28,"profit":true},{"date":"2021-12-31","value":54.93,"profit":true},{"date":"2022-12-31","value":23.94,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

ALKS
Cash Ratio 2.00
Current Ratio 3.45
Quick Ratio 3.03

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

ALKS
ROA (LTM) 8.98%
ROE (LTM) 29.23%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

ALKS
Debt Ratio Lower is generally better. Negative is bad. 0.40
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.60

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

ALKS
Trailing PE 12.87
Forward PE 20.66
P/S (TTM) 3.17
P/B 3.69
Price/FCF 65
EV/R 2.81
EV/Ebitda 10.66
PEG NM

FAQs

What is Alkermes Plc share price today?

Alkermes Plc (ALKS) share price today is $29.47

Can Indians buy Alkermes Plc shares?

Yes, Indians can buy shares of Alkermes Plc (ALKS) on Vested. To buy Alkermes Plc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in ALKS stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Alkermes Plc be purchased?

Yes, you can purchase fractional shares of Alkermes Plc (ALKS) via the Vested app. You can start investing in Alkermes Plc (ALKS) with a minimum investment of $1.

How to invest in Alkermes Plc shares from India?

You can invest in shares of Alkermes Plc (ALKS) via Vested in three simple steps:

  • Click on Sign Up or Invest in ALKS stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Alkermes Plc shares
What is Alkermes Plc 52-week high and low stock price?

The 52-week high price of Alkermes Plc (ALKS) is $32.88. The 52-week low price of Alkermes Plc (ALKS) is $22.9.

What is Alkermes Plc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Alkermes Plc (ALKS) is 12.869

What is Alkermes Plc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Alkermes Plc (ALKS) is 3.69

What is Alkermes Plc dividend yield?

The dividend yield of Alkermes Plc (ALKS) is 0.00%

What is the Market Cap of Alkermes Plc?

The market capitalization of Alkermes Plc (ALKS) is $4.99B

What is Alkermes Plc’s stock symbol?

The stock symbol (or ticker) of Alkermes Plc is ALKS

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top